
CURE SYNGAP1 CURE SYNGAP1 (FKA SynGAP Research Fund) is a 501(c)(3) public charity incorporated in 2018. The mission is to improve the quality of life of SYNGAP1 patients through the research and development of treatments, therapies and support systems. Completely family led, CURE SYNGAP1 is a leading funder of SYNGAP1 research. CURE SYNGAP1’s mantra is Collaboration, Transparency & Urgency. CURE SYNGAP1 is a member of COMBINEDBrain, The Research Acceleration and Innovation Network (TRAIN), the Personalized Medicine Coalition, the Global Genes Global Advocacy Alliance, the Everylife Foundation Community Congress, & the Innovation and Value Initiative. CURE SYNGAP1 is committed to serving all members of the community regardless of age, race, color, religion, creed, citizenship status, marital status, sexual orientation, sex, gender identity, genetic information, national origin, disability, veteran status or any other protected status under applicable law. Patient Advocacy Organization

CURE SYNGAP1

CURE SYNGAP1 (FKA SynGAP Research Fund) is a 501(c)(3) public charity incorporated in 2018. The mission is to improve the quality of life of SYNGAP1 patients through the research and development of treatments, therapies and support systems. Completely family led, CURE SYNGAP1 is a leading funder of SYNGAP1 research. CURE SYNGAP1’s mantra is Collaboration, Transparency & Urgency. CURE SYNGAP1 is a member of COMBINEDBrain, The Research Acceleration and Innovation Network (TRAIN), the Personalized Medicine Coalition, the Global Genes Global Advocacy Alliance, the Everylife Foundation Community Congress, & the Innovation and Value Initiative. CURE SYNGAP1 is committed to serving all members of the community regardless of age, race, color, religion, creed, citizenship status, marital status, sexual orientation, sex, gender identity, genetic information, national origin, disability, veteran status or any other protected status under applicable law.

Patient Advocacy Organization